Particularly, SPARC and SPP1 expression were positively correlated to DC-related markers CD86, NRP1, and inhibitory checkpoint markers including LAIR1, HAVCR2, and PDCDLG2 in most cancer types. This evidence concerns the gene NRP1 and cancer.